This site is intended for healthcare professionals
News

Pfizer and BioNTech conclude phase III study of BNT162b2 vaccine for COVID-19 meeting all primary endpoints.

Read time: 1 mins
Last updated:20th Nov 2020
Published:20th Nov 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com